Targeted therapies of solid cancers: new options, new challenges.

Auteurs : Awada A, Aftimos P
Jaar : 2013
Journal : Curr Opin Oncol
Volume : 25(3)
Pagina's : 296-304

Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology.

Auteurs : Awada A, Vandone AM, Aftimos P
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pagina's : 297-304

mTor inhibition in RCC: proof of concept, clinical use, and future directions,

Auteurs : Aftimos P, Awada A, Gil T
Jaar : 2011
Journal : Belgian J Medical Oncology
Volume : 5(5)
Pagina's : 205-11

Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?

Auteurs : Aftimos P, Awada A
Jaar : 2011
Journal : Adv Ther
Volume : 28(11)
Pagina's : 973-85